Our results showed that in the Purinergic gene low expression group, the expression levels of histone modifier genes (such as SIRT and HDAC) as well as classical oncogenes had highly significant differences compared to the other two groups (Purinergic gene high expression group and Purinergic gene normal expression group).
← all excerpts
The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.
1
—
—